Clinical Impact of Pre-Procedural Percutaneous Coronary Intervention in Low- and Intermediate-Risk Transcatheter

Max-Paul Winter1, Thomas M Hofbauer1, Philipp E Bartko1

  • 1Department of Cardiology, Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

Insights

Complete revascularization before transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS) in low- and intermediate-risk patients is safe. This strategy showed no difference in all-cause mortality compared to patients without significant coronary artery disease (CAD).

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Optimal treatment for coronary artery disease (CAD) in patients undergoing transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS) remains unclear, especially in low- and intermediate-risk populations.
  • Existing data are conflicting and primarily focus on high-risk patients.

Purpose of the Study:

  • To investigate the feasibility and safety of complete revascularization before TAVR in low- and intermediate-risk patients with severe AS.
  • To assess the impact of recent (<3 months) and prior (>3 months) complete revascularization on clinical outcomes.

Main Methods:

  • A cohort of 449 patients at low (STS score < 4%) and intermediate risk (STS score 4-8%) undergoing TAVR for severe AS was enrolled.
  • The study analyzed the influence of complete revascularization timing on all-cause mortality, the primary endpoint.
  • Cox regression analysis was used to evaluate the effect of recent revascularization on mortality.

Main Results:

  • 58% of patients had no or non-significant CAD; 18% had prior complete revascularization, and 24% had recent complete revascularization before TAVR.
  • Two-year all-cause mortality was similar between patients with recent revascularization (13.7%) and those with no or non-significant CAD (14.2%; p = 0.905).
  • Recent revascularization prior to TAVR did not significantly affect all-cause mortality in Cox regression analysis.

Conclusions:

  • Complete percutaneous revascularization performed shortly before TAVR is a safe strategy in low- and intermediate-risk patients with severe AS.
  • This approach is neutral regarding all-cause mortality, offering reassurance for clinical decision-making.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
315
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
78
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
318
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
74
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
286